Venipuncture

PreclinicalBiologic

AAssistance Publique Hopitaux De Marseille

Venipuncture is one of 6 biologic programs targeting Pre-Term. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Pre-TermTerminated

Pre-TermPreclinical

Terminated

Competition

Competitive Landscape

6 competitors in Pre-Term

#DrugCompanyPhaseTrials

Zithromax

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Approved

2 2

Citicoline

UUniversity of Texas Southwestern Medical Center

Phase 3

1 3

L-Carnitine

IIperboreal Pharma Srl

Preclinical

1 4

Blood Puncture Site

AAssistance Publique Hopitaux De Marseille

Preclinical

1 5

Infasurf

RRoberta Ballard

Preclinical

1 6

Venipuncture

AAssistance Publique Hopitaux De Marseille

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Pre-Term1 trial

The Calming Effect of Vanilla Odor on Preterm Infant Without Mother's Breast Milk Feeding

Terminated·AAssistance Publique Hopitaux De Marseille·N/A·NCT03626974·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Venipuncture. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Venipuncture compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Venipuncture. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Assistance Publique Hopitaux De Marseille company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: AAssistance Publique Hopitaux De Marseille

Venipuncture

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Pre-Term1 trial

References

Drug Info

Quick Facts

Related News